Sector: MedicalDynavax Technologies Corporation (NASDAQ: DVAX)
Headlines
- Dynavax Completes Enrollment of First Cohort of Patients in Phase 1b Clinical Trial for Hepatitis B Therapy
Nov 19, 2009 06:45 AM | DVAX
- Dynavax to Acquire Symphony Dynamo, Inc., Including $20 Million in Unrestricted Cash
Nov 10, 2009 06:49 AM | DVAX
- Dynavax Appoints Francis R. Cano, Ph.D. to Board of Directors
Nov 05, 2009 06:45 AM | DVAX
- Dynavax's HEPLISAV Shows Increased Protection Rate for Chronic Kidney Disease Patients
Oct 29, 2009 04:00 PM | DVAX
- Dynavax Announces Third Quarter 2009 Financial Results
Oct 22, 2009 04:00 PM | DVAX
- Dynavax to Report Third Quarter 2009 Financial Results after Market Closes on October 22, 2009
Oct 21, 2009 04:36 PM | DVAX
- Dynavax to Present at the Oppenheimer Healthcare Conference
Oct 20, 2009 06:45 AM | DVAX
- Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak
Oct 14, 2009 11:06 AM | BCRX, DVAX, GILD, HEB, SVA
- Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney Disease Patients for HEPLISAVTM Hepatitis B Vaccine
Sep 29, 2009 06:45 AM | DVAX
- Dynavax Announces HEPLISAVTM Data to Be Presented at IDSA Medical Conference
Sep 22, 2009 06:45 AM | DVAX
- Dynavax Announces Retirement of Chief Financial Officer
Aug 07, 2009 04:06 PM | DVAX
- Dynavax Announces Second Quarter 2009 Financial Results
Aug 04, 2009 04:26 PM | DVAX
- Dynavax Announces Path for HEPLISAVTM Hepatitis B Vaccine Development
Aug 04, 2009 04:19 PM | DVAX
- Dynavax Presents Additional Phase 3 Data for HEPLISAVTM Hepatitis B Vaccine at DDW Medical Conference
Jun 03, 2009 09:17 AM | DVAX
- Dynavax Announces Data Presentations at American Thoracic Society Medical Conference
May 18, 2009 06:47 AM | DVAX
- Dynavax Awarded Grant to Support Development of TLR Inhibitors in Skin Diseases
May 13, 2009 06:46 AM | DVAX
- Dynavax Presents Data From Novel Universal Flu Vaccine Candidate
Apr 30, 2009 06:04 AM | DVAX
- Dynavax Announces First Quarter 2009 Financial Results
Apr 28, 2009 04:35 PM | DVAX
- Dynavax Presents Additional Phase 3 Data for HEPLISAV™ Hepatitis B Vaccine at EASL Medical Conference
Apr 27, 2009 06:46 AM | DVAX
- Dynavax Announces Extension of AstraZeneca Research Collaboration
Mar 11, 2009 06:46 AM | DVAX
- Form 4 CANO FRANCIS For: Nov 03 (10K)
Nov 05, 2009 07:28 PM
- Form 3 CANO FRANCIS For: Nov 03 (10K)
Nov 05, 2009 07:16 PM
- Form 4 LAMPERT MARK N For: Sep 10 (10K)
Sep 11, 2009 07:08 PM
- Form 4 DYNAVAX TECHNOLOGIES For: Aug 05 Filed by: BVF INC/IL (10K)
Aug 10, 2009 10:48 AM
- Form 4 LAMPERT MARK N For: Jul 30 (10K)
Aug 03, 2009 07:07 PM
- Form 4 LAMPERT MARK N For: Jul 27 (10K)
Jul 29, 2009 06:19 PM
- Form 4 Plotkin Stanley A For: May 13 (10K)
Jun 12, 2009 06:38 PM
- Form 4 Phillips Peggy V For: May 13 (10K)
Jun 12, 2009 06:38 PM
- Form 4 DYNAVAX TECHNOLOGIES For: May 13 Filed by: ORONSKY ARNOLD L (10K)
Jun 12, 2009 06:38 PM
- Form 4 DYNAVAX TECHNOLOGIES For: May 13 Filed by: LAWRENCE DAVID M (10K)
Jun 12, 2009 06:35 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
DVAX
|
Compare to S&P
|
| YTD |
55.95 %
|
28.82 %
|
| 4 Weeks |
-26.36 %
|
-26.75 %
|
| 12 Weeks |
-20.61 %
|
-25.50 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -340.00 %
|
|
EPS Growth in Last Year: -71.43 %
|
|
Sales Growth in Last Quarter: -81.74 %
|
|
Sales Growth in Last Quarter: -67.25 %
|
|
